Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Immuron Limited (IMC)
  6. Company Announcements

Immuron Limited (ASX: IMC) - Announcements

Current share price for IMC : $0.092 0.002 (2.13%)

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Immuron Limited (IMC)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$21 Results for Announcement to the Market 31 Aug 2012 12:32PM $0.018 $0.092 $0.090 risen by 411.11%
$21 Influenza program for Swine Flu 15 Aug 2012 8:48AM $0.018 $0.092 $0.090 risen by 411.11%
$21 NIH Grant for Immuron's IMM 124E for Alcholic Fatty Liver 6 Aug 2012 10:05AM $0.016 $0.092 $0.090 risen by 475%
$21 Prospectus for Bonus Issue of Options 9 Jul 2012 11:26AM $0.022 $0.092 $0.090 risen by 318.18%
$21 Finalisation of Share Purchase Plan 18 Jun 2012 8:33AM $0.019 $0.092 $0.090 risen by 384.21%
$21 Travelan application - Canada 4 Jun 2012 9:27AM $0.018 $0.092 $0.090 risen by 411.11%
$21 Travelan Distribution in Singapore, Malaysia and Brunei 14 May 2012 9:41AM $0.018 $0.092 $0.090 risen by 411.11%
$21 Travelan licensed to Thailand, Hong Kong, Cambodia, Vietnam 10 May 2012 9:45AM $0.018 $0.092 $0.090 risen by 411.11%
$21 Agreement with Synlait Milk for Hyperimmune requirements 7 May 2012 9:44AM $0.017 $0.092 $0.090 risen by 441.18%
$21 Reinstatement to Official Quotation 23 Apr 2012 10:19AM $0.020 $0.092 $0.090 risen by 360%
$21 Capital Raising announcement 23 Apr 2012 10:19AM $0.020 $0.092 $0.090 risen by 360%
$21 Suspension from Official Quotation 20 Apr 2012 9:35AM $0.026 $0.092 $0.090 risen by 253.85%
$21 Trading Halt Request 18 Apr 2012 9:11AM $0.026 $0.092 $0.090 risen by 253.85%
$21 Trading Halt 18 Apr 2012 9:07AM $0.026 $0.092 $0.090 risen by 253.85%
$21 Immuron appoints Joe Baini Chief Executive Officer 5 Mar 2012 9:14AM $0.030 $0.092 $0.090 risen by 206.67%
$21 Half Yearly Report and Accounts 28 Feb 2012 1:28PM $0.032 $0.092 $0.090 risen by 187.50%
$21 Immuron and Monash University to Collaborate on C. difficile 31 Jan 2012 10:15AM $0.042 $0.092 $0.090 risen by 119.05%
$21 Immuron finalises funding facility 16 Jan 2012 9:46AM $0.054 $0.092 $0.090 risen by 70.37%
$21 IND cleared for NASH/Fatty Liver Phase IIb trials 10 Jan 2012 9:07AM $0.050 $0.092 $0.090 risen by 84%
$21 Research agreement with Harvard Medical School 16 Dec 2011 9:26AM $0.040 $0.092 $0.090 risen by 130%
$21 Travelan Licence Deal with Paladin Labs Inc. Canada 29 Nov 2011 9:17AM $0.050 $0.092 $0.090 risen by 84%
$21 Immuron submits NASH IND Application with FDA 7 Nov 2011 9:29AM $0.050 $0.092 $0.090 risen by 84%
$21 Non-Renounceable Issue Shortfall 4 Nov 2011 1:05PM $0.050 $0.092 $0.090 risen by 84%
$21 Offer Document for Non-Renounceable Rights Issue 31 Aug 2011 2:04PM $0.065 $0.092 $0.090 risen by 41.54%
$21 Results for Announcement to the Market 31 Aug 2011 12:55PM $0.050 $0.092 $0.090 risen by 84%

551 - 575 of 612 results

Page 23 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.